TotalMarketCap

Inovio Pharmaceuticals

INONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$150.443 M

$1.46 -10.19%

Close of 6 Nov 2026

As of 6 Nov 2026, Inovio Pharmaceuticals (INO) has a market capitalization of $150.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$65.3K

#3579 by revenue

Earnings

-$85.0M

Loss-making

Shares outstanding

103,397,518

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #260PepGenPEPG$160.3M
  2. #261Canton StrategicCNTN$152.6M
  3. #262Inovio PharmaceuticalsINO$150.4M
  4. #263AN2 TherapeuticsANTX$149.8M
  5. #264Sionna TherapeuticsSION$147.8M

What if Inovio Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$273,090.44

Per share 187,691× higher

Bitcoin $1.53T

$14,776.45

Per share 10,156× higher

Apple $5.02T

$48,509.70

Per share 33,340× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Inovio Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.